Target
Insulin-like growth factor-binding protein 5
Ligand
BDBM50128459
Substrate
n/a
Meas. Tech.
ChEBML_90543
Ki
13±n/a nM
Citation
 Zhu, YFWang, XCConnors, PWilcoxen, KGao, YGross, RStrack, NGross, TMcCarthy, JRXie, QLing, NChen, C Quinoline-carboxylic acids are potent inhibitors that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins. Bioorg Med Chem Lett 13:1931-4 (2003) [PubMed]  Article 
Target
Name:
Insulin-like growth factor-binding protein 5
Synonyms:
IBP5 | IBP5_HUMAN | IGFBP5 | Insulin-like growth factor binding protein 5
Type:
PROTEIN
Mol. Mass.:
30581.07
Organism:
Homo sapiens (Human)
Description:
ChEMBL_90411
Residue:
272
Sequence:
MVLLTAVLLLLAAYAGPAQSLGSFVHCEPCDEKALSMCPPSPLGCELVKEPGCGCCMTCALAEGQSCGVYTERCAQGLRCLPRQDEEKPLHALLHGRGVCLNEKSYREQVKIERDSREHEEPTTSEMAEETYSPKIFRPKHTRISELKAEAVKKDRRKKLTQSKFVGGAENTAHPRIISAPEMRQESEQGPCRRHMEASLQELKASPRMVPRAVYLPNCDRKGFYKRKQCKPSRGRKRGICWCVDKYGMKLPGMEYVDGDFQCHTFDSSNVE
  
Inhibitor
Name:
BDBM50128459
Synonyms:
4-(3,4-Dihydroxy-benzyl)-6,7-dihydroxy-quinoline-2-carboxylic acid | CHEMBL56978
Type:
Small organic molecule
Emp. Form.:
C17H13NO6
Mol. Mass.:
327.2882
SMILES:
OC(=O)c1cc(Cc2ccc(O)c(O)c2)c2cc(O)c(O)cc2n1
Structure:
Search PDB for entries with ligand similarity: